Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

E. Stryjewski, Martín; O'Riordan, W.; K. Lau, William; D. Pien, Francis; M. Dunbar, Lala; Vallee, M; G. Fowler, Vance; H. Chu, Vivian; Adekola Torimiro Spencer, Eden; L. Barriere, Steven; M. Kitt, Michael; H. Cabell, C.; Ralph Corey, G.; FAST Investigator Group, the

doi:10.1086/429914

Public

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

Published in Clinical Infectious Diseases • May 6, 2005

Authors:

Martín E. Stryjewski

W. O'Riordan

William K. Lau

Abstract

BACKGROUND: Telavancin, a novel lipoglycopeptide, exerts concentration-dependent, rapid bactericidal activity on account of its multiple mechanisms of action. Telavancin is highly active against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermed...

Subject

Medicine

Soft tissue

Gram-positive bacterial infections

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!